Why Drug Launches Are Won Years Before Approval with Ana Bozas

Episode notes

Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. Pharma Sessions is hosted by Jonathan Kaskey

• The Question Behind the Question - Field Training with Jennifer Muszik47 / 100
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce46 / 100
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury49 / 100
• Timothy Smith on AI, Data, and Drug Discovery at Takeda
• Lessons on Leading Through Uncertainty in Pharma